BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28402189)

  • 1. Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side.
    Hudecek M; Izsvák Z; Johnen S; Renner M; Thumann G; Ivics Z
    Crit Rev Biochem Mol Biol; 2017 Aug; 52(4):355-380. PubMed ID: 28402189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells.
    Ye L; Lam SZ; Yang L; Suzuki K; Zou Y; Lin Q; Zhang Y; Clark P; Peng L; Chen S
    Nat Biomed Eng; 2024 Feb; 8(2):132-148. PubMed ID: 37430157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.
    Liu G; Aronovich EL; Cui Z; Whitley CB; Hackett PB
    J Gene Med; 2004 May; 6(5):574-83. PubMed ID: 15133768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transposon and transposase system for human application.
    Hackett PB; Largaespada DA; Cooper LJ
    Mol Ther; 2010 Apr; 18(4):674-83. PubMed ID: 20104209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sleeping Beauty transposon system: a non-viral vector for gene therapy.
    Aronovich EL; McIvor RS; Hackett PB
    Hum Mol Genet; 2011 Apr; 20(R1):R14-20. PubMed ID: 21459777
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kovač A; Miskey C; Ivics Z
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity.
    Peng PD; Cohen CJ; Yang S; Hsu C; Jones S; Zhao Y; Zheng Z; Rosenberg SA; Morgan RA
    Gene Ther; 2009 Aug; 16(8):1042-9. PubMed ID: 19494842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.
    Bexte T; Botezatu L; Miskey C; Gierschek F; Moter A; Wendel P; Reindl LM; Campe J; Villena-Ossa JF; Gebel V; Stein K; Cathomen T; Cremer A; Wels WS; Hudecek M; Ivics Z; Ullrich E
    Mol Ther; 2024 May; ():. PubMed ID: 38751112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mage transposon: a novel gene delivery system for mammalian cells.
    Tian J; Tong D; Li Z; Wang E; Yu Y; Lv H; Hu Z; Sun F; Wang G; He M; Xia T
    Nucleic Acids Res; 2024 Mar; 52(5):2724-2739. PubMed ID: 38300794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.
    Hackett PB; Aronovich EL; Hunter D; Urness M; Bell JB; Kass SJ; Cooper LJ; McIvor S
    Curr Gene Ther; 2011 Oct; 11(5):341-9. PubMed ID: 21888621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the piggyBac transposon using mRNA and insulators: toward a more reliable gene delivery system.
    Bire S; Ley D; Casteret S; Mermod N; Bigot Y; Rouleux-Bonnin F
    PLoS One; 2013; 8(12):e82559. PubMed ID: 24312663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection.
    Bell JB; Podetz-Pedersen KM; Aronovich EL; Belur LR; McIvor RS; Hackett PB
    Nat Protoc; 2007; 2(12):3153-65. PubMed ID: 18079715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minicircle Delivery to the Neural Retina as a Gene Therapy Approach.
    Staurenghi F; McClements ME; Salman A; MacLaren RE
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo.
    Podetz-Pedersen KM; Vezys V; Somia NV; Russell SJ; McIvor RS
    Hum Gene Ther; 2014 Nov; 25(11):955-65. PubMed ID: 25093708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Naturally Active Spy Transposon Discovered from the Insect Genome of Colletes gigas as a Promising Novel Gene Transfer Tool.
    Diaby M; Wu H; Gao B; Shi S; Wang B; Wang S; Wang Y; Wu Z; Chen C; Wang X; Song C
    Adv Sci (Weinh); 2024 May; ():e2400969. PubMed ID: 38774947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-viral therapeutic approaches to ocular diseases: An overview and future directions.
    Zulliger R; Conley SM; Naash MI
    J Control Release; 2015 Dec; 219():471-487. PubMed ID: 26439665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic engineering of stem cells for enhanced therapy.
    Nowakowski A; Andrzejewska A; Janowski M; Walczak P; Lukomska B
    Acta Neurobiol Exp (Wars); 2013; 73(1):1-18. PubMed ID: 23595280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hybrid vectors for somatic integration - are they the better solution?
    Müther N; Noske N; Ehrhardt A
    Viruses; 2009 Dec; 1(3):1295-324. PubMed ID: 21994594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale analysis of delayed recognition using sleeping beauty and the prince.
    Miura T; Asatani K; Sakata I
    Appl Netw Sci; 2021; 6(1):48. PubMed ID: 34226873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empowering gene delivery with protein engineering platforms.
    Kizerwetter M; Pietz K; Tomasovic LM; Spangler JB
    Gene Ther; 2023 Dec; 30(12):775-782. PubMed ID: 36529795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.